Kavar Capital Partners Group’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1	Closed	–	–	180
2014 Q1	$0	Hold	1	–	–	﹤0.01%	533
2013 Q4	$0	Buy	+1	New	–	﹤0.01%	502